Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 known ✓ | Q9H244 | 5/20 | 0.34 |
| ▸ | P2RY2 known ✓ | P41231 | 5/20 | 0.34 |
| ▸ | P2RY4 known ✓ | P51582 | 4/20 | 0.32 |
| ▸ | P2RY6 known ✓ | Q15077 | 2/20 | 0.32 |
| ▸ | P2RY1 known ✓ | P47900 | 2/20 | 0.31 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.30 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.35 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.35 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.34 |
| ▸ | FUT8 | Q9BYC5 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38654920 | 0.91 | FUT8 (0.35) | FUT8 | |
| SCHEMBL12173125 | 0.85 | FUT8 (0.35) | FUT8 | |
| SCHEMBL12974319 | 0.78 | FUT8 (0.33) | FUT8 | |
| SCHEMBL14367149 | 0.76 | FUT8 (0.33) | FUT8 | |
| SCHEMBL16373350 | 0.76 | CARM1 (0.35) | CARM1PRMT1P2RY12P2RY2P2RX2 | |
| SCHEMBL20390575 | 0.76 | FUT8 (0.40) | CARM1PRMT1P2RY12P2RY2P2RX2 | |
| SCHEMBL12173082 | 0.76 | FUT8 (0.38) | CARM1PRMT1P2RY12P2RY2P2RX2 | |
| SCHEMBL12646575 | 0.76 | FUT8 (0.38) | CARM1PRMT1P2RY12P2RY2P2RX2 | |
| SCHEMBL14495144 | 0.75 | FUT8 (0.35) | FUT8USP2APEX1 | |
| SCHEMBL14468747 | 0.73 | FUT8 (0.37) | CARM1PRMT1FUT8USP2APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240399110-A1 | ARTICLES COMPRISING MARKINGS AND RELATED METHODS | Access Vascular, Inc. (US) | 2024-12-05 | — | — | US | claimed |
| US-11992627-B2 | Articles comprising markings and related methods | Access Vascular, Inc. (US) | 2024-05-28 | — | — | US | claimed |
| EP-4171704-A1 | ARTICLES COMPRISING MARKINGS AND RELATED METHODS | Access Vascular, Inc. (US) | 2023-05-03 | — | — | EP | claimed |
| CN-115989054-A | Articles comprising indicia and related methods | 阿塞斯血管有限公司 | 2023-04-18 | — | — | CN | claimed |
| US-20220088348-A1 | ARTICLES COMPRISING MARKINGS AND RELATED METHODS | Access Vascular, Inc. (US) | 2022-03-24 | — | — | US | claimed |
| WO-2026105013-A1 | CONTACT LENSES WITH COLOR FILTERING ZONE | ALCON INC. (CH) | 2026-05-21 | — | — | WO | disclosed |
| US-12629345-B2 | Methods, compositions, and devices for drug / live cell microarrays | PATHAK HOLDINGS LLC (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260097181-A1 | GRADIENT ANNEALING OF POLYMERIC COMPONENTS | Access Vascular, Inc. (US) | 2026-04-09 | — | — | US | disclosed |
| WO-2025264839-A1 | GRADIENT ANNEALING OF POLYMERIC COMPONENTS | Access Vascular, Inc. (US) | 2025-12-26 | — | — | WO | disclosed |
| US-20250332318-A1 | POLYMER PARTICLES | TERUMO CORP (JP) | 2025-10-30 | — | — | US | disclosed |
| US-12447228-B2 | Polymer particles | TERUMO CORPORATION (JP) | 2025-10-21 | — | — | US | disclosed |
| US-12364786-B2 | Polymer particles | TERUMO CORPORATION (JP) | 2025-07-22 | — | — | US | disclosed |
| US-20220176012-A1 | PARTICLES | MICROVENTION, INC. | 2022-06-09 | — | — | US | disclosed |
| US-20220144990-A1 | POLYMER PARTICLES | TERUMO CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20220118416-A1 | CROSSLINKED MULTILAYERED MATERIAL COMPOSITIONS, METHODS FOR THEIR PREPARATION AND APPLICATIONS THEREOF | PATHAK HOLDINGS LLC | 2022-04-21 | — | — | US | disclosed |
| US-11285240-B2 | Particles | MICROVENTION, INC. (US) | 2022-03-29 | — | — | US | disclosed |
| CN-109575689-B | Ink for ink jet printing, ink set for ink jet printing, and printing method | 精工爱普生株式会社 | 2022-03-25 | — | — | CN | disclosed |
| US-20220088348-A1 | ARTICLES COMPRISING MARKINGS AND RELATED METHODS | Access Vascular, Inc. (US) | 2022-03-24 | — | — | US | disclosed |
| US-11261274-B2 | Polymer particles | TERUMO CORPORATION (JP) | 2022-03-01 | — | — | US | disclosed |
| CN-109789222-B | Polymer particles | 泰尔茂株式会社 | 2022-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629345-B2 | Methods, compositions, and devices for drug / live cell microarrays | SRMS, FKBP4, MYL4 | P2RY12 2383/4885P2RY2 2322/4885P2RY4 1768/4885 |
| US-20250332318-A1 | POLYMER PARTICLES | FGB, PLG, PLAT | P2RY12 2854/4885P2RY2 3115/4885P2RY4 3351/4885 |
| US-12447228-B2 | Polymer particles | PCBP1, LCP1, PSAP | P2RY12 4225/4885P2RY2 4454/4885P2RY4 4484/4885 |
| US-12364786-B2 | Polymer particles | FGB, PLG, PLAT | P2RY12 2854/4885P2RY2 3115/4885P2RY4 3351/4885 |
| US-20260097181-A1 | GRADIENT ANNEALING OF POLYMERIC COMPONENTS | AQP3, AQP1, ELOC | P2RY12 4055/4885P2RY2 4099/4885P2RY4 4452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.